Two-in-one approach could help keep brain cancer in check

Glioblastoma is not only the most common form of brain cancer, it’s also the most deadly. It affects people from around 40 years of age, and most people live for less than 2 years after aggressive therapy. Now scientists report that a two-in-one approach could help keep brain cancer in check.